These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27382985)

  • 1. Immunosuppression in idiopathic membranous nephropathy: A double-edge sword.
    L'Imperio V; Ajello E; Garozzo M; Tosoni A; Ferrario F; Pagni F
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):775-777. PubMed ID: 27382985
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive therapy for idiopathic membranous glomerulopathy].
    Branten AJ; Wetzels JF
    Ned Tijdschr Geneeskd; 1998 Apr; 142(14):767-72. PubMed ID: 9646608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranous Nephropathy: The Journey Continues ….
    Hoxha E; Stahl RA
    EBioMedicine; 2015 May; 2(5):374-5. PubMed ID: 26137581
    [No Abstract]   [Full Text] [Related]  

  • 4. Membranous glomerulonephritis. Towards tailor-made treatment?
    Nieuwhof CM; Gaillard CA; van Breda Vriesman PJ
    Neth J Med; 1993 Apr; 42(3-4):109-11. PubMed ID: 8316322
    [No Abstract]   [Full Text] [Related]  

  • 5. Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis.
    Hirayama K; Ebihara I; Yamamoto S; Kai H; Muro K; Yamagata K; Kobayashi M; Koyama A
    Nephron; 2002 Jun; 91(2):255-61. PubMed ID: 12053062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cyclosporin have a role in the treatment of membranous nephropathy?
    Ponticelli C; Villa M
    Nephrol Dial Transplant; 1999 Jan; 14(1):23-5. PubMed ID: 10052467
    [No Abstract]   [Full Text] [Related]  

  • 8. Segmental membranous nephropathy with severe IgG3 deposition.
    Kondo A; Hashimura Y; Uchiyama T; Yoshikawa N; Minami H
    Pediatr Int; 2018 Jun; 60(6):597-598. PubMed ID: 29744961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppression in membranous glomerulonephritis - pro].
    Stahl RA
    Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1686. PubMed ID: 19707965
    [No Abstract]   [Full Text] [Related]  

  • 10. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy.
    Kuroki A; Iyoda M; Shibata T; Sugisaki T
    Kidney Int; 2005 Jul; 68(1):302-10. PubMed ID: 15954921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of igG4 subclass and cellular immunity in idiopathic membranous nephropathy].
    Kuroki A; Akisawa T
    Nihon Jinzo Gakkai Shi; 2011; 53(5):668-71. PubMed ID: 21842598
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.
    Medrano AS; Escalante EJ; Cáceres CC; Pamplona IA; Allende MT; Terrades NR; Carmeno NV; Roldán EO; Agudelo KV; Vasquez JJ
    Biomarkers; 2015 Feb; 20(1):77-83. PubMed ID: 25519165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study.
    Yang Y; Wang C; Jin L; He F; Li C; Gao Q; Chen G; He Z; Song M; Zhou Z; Shan F; Qi K; Ma L
    Immunol Res; 2016 Aug; 64(4):919-30. PubMed ID: 26837241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous nephropathy: an IgG4-mediated disease.
    Oliveira DB
    Lancet; 1998 Feb; 351(9103):670-1. PubMed ID: 9500350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human idiopathic membranous nephropathy--a mystery solved?
    Glassock RJ
    N Engl J Med; 2009 Jul; 361(1):81-3. PubMed ID: 19571287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic value of IgG subtypes in membranous nephropathy: A case report].
    Asmandar S; Figuères ML; Goujon JM; Noël LH; Hummel A
    Nephrol Ther; 2015 Jun; 11(3):169-72. PubMed ID: 25921735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous glomerulonephropathy associated with psoriasis vulgaris.
    Sakemi T; Hayashida R; Ikeda Y; Baba N; Nishihara G; Kohda H
    Nephron; 1996; 72(2):351-2. PubMed ID: 8684567
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of malignancy after treatment of idiopathic membranous nephropathy.
    Lai MY; Yang WC; Lin CC
    Kidney Int; 2004 Jul; 66(1):464; author reply 464-5. PubMed ID: 15200468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppression in membranous glomerulonephritis - contra].
    Wüthrich RP
    Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1687. PubMed ID: 19707966
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiopathic membranous nephropathy in 2 twin brothers.
    Vangelista A; Tazzari R; Bonomini V
    Nephron; 1988; 50(1):79-80. PubMed ID: 3173611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.